Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
July 14, 2026
AMA Launches Interoperability Initiative to Advance Electronic Prior Authorization
Dompé Enrolls First Patient in Global Phase 3 Trial of Intranasal NGF Therapy for NAION
July 10, 2026
Opus Genetics Provides BEST1 Program Update
July 9, 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
